From ‘Magic Mushrooms’ to Medicine: What Clinicians Should Know About Psilocybin-Assisted Therapy
***NOTE: This training discusses psilocybin and other psychedelic substances in the context of mental health. It is intended for adults 21 years and older. The content is for educational purposes only.***
Psilocybin assisted therapy (PAT) is quickly gaining national attention as a major clinical tool to address a variety of mental health concerns, including treatment resistant major depression, generalized anxiety disorder, OCD, and PTSD. This treatment is now accessible in several states, including Colorado where our presenters are located. This presentation will provide an introduction to P...Read moreAT, including historical contexts, proposed mechanisms of action, the phases of treatment, and unique considerations. There are no known risk to attendees of this presentation. Treatment using this approach is still federally illegal and additional specialized training and licensure is required to complete this treatment with patients. Therefore, this presentation is informational and does not train attendees to use this approach with patients. Less...
Learning Objectives
- Name the three stages of treatment in PAT
- Identify at least three rule outs for treatment
- Describe how therapists’ roles during PAT differ from traditional talk therapy
- Describe at least one proposed mechanism of action of PAT
Target Audience
Learning Levels
- Introductory – Content is designed for psychologists who may have little to no background in a specialized skill or content area. Through this level of programming, the learner can become acquainted with the theoretical underpinnings, principles, methods, and perspectives of a content area. An introductory level program also may serve as the foundation for subsequent intermediate and advanced learning. Introductory level programing may also be related to an emerging area of knowledge or practice. Although this content can be used as a foundation for more advanced learning, an introductory level program may simply focus on breadth, enrichment or general knowledge.
Friday, March 13, 2026
10:00 AM MDT - 12:00 PM MDT
Click Here to Register
About the speakers
Alex Ertl, Psy.D.
Michelle Ertl, Psy.D.
Agenda
10:00 a.m. - 12:00 p.m. MST
Instructional methods include encouraged reflection of participants’ personal biases, use of a case example, and use of audience polls.
There are no scheduled breaks.
CE Information - Earn 2 CE Credit Hours
CE Approvals
Agency Approvals
CE Process Info
Before the event, you will receive an email from CE-Go with access to the virtual event. After the event, you will receive access to your evaluation and continuing education certificate via a personalized "Attendee Dashboard" link, hosted on the CE-Go website. This link and access to the virtual event will be sent to the email account you used to register for the event.
Upon accessing the CE-Go "attendee dashboard", you will be able to:
- Complete evaluation forms for the event
- Download your continuing education certificate in a PDF format
If you have any questions or concerns regarding the CE-Go platform, please contact CE-Go at 888-498-5578 or by email at support@ce-go.com Please Note: Emails for this event will come from "support@ce-go.com".
If you have any continuing education related questions, please contact your event organizer.
Please make sure to check your spam/junk folder in case those emails get "stuck". We'd also suggest "Allowlisting" support@ce-go.com. This tells your email client that you know this sender and trust them, which will keep emails from this contact at the top of your inbox and out of the junk folder.
Disclosure
Thank you for your interest in attending our events! 100% of the proceeds from these events directly supports pro bono and sliding scale services at UCEBT.While academic and professional research has for decades investigated the effects of psychedelics broadly and psilocybin, the existing body research and conclusions is less extensive compared to other traditional psychotherapies . The presenters will present findings and acknowledge where these findings are tentative or early in development. Treatment using this approach is still federally illegal and additional specialized training and licensure is required to complete this treatment with patients. Therefore, this presentation is for informational purposes only and does not train attendees to use this approach with patients and clinicians are not encouraged to utilize psychedelic substances with their clients outside state-specific legal models. Utilization of psilocybin with clients outside of the state-specific legal model may result in harm to the client, the clinician, and the psychedelic movement at large.
Commercial Support: None.
Proceeds from the talk will be supporting our pro bono and sliding scale program.
AI Disclosure: AI was not used in the generation of this training.
CE Credit:
Two hours of CE credit is available for attendees who are present for the entire program. UCEBT is approved by the American Psychological Association to sponsor continuing education for psychologists. UCEBT maintains responsibility for this program and its content. UCEBT trainings also provide CE credit through NASW-UT, UMHCA, and UAMFT.
We ask that all participants return the post-program evaluation form at the conclusion of the program. Presenter(s) and UCEBT have not received any commercial support for this program or its contents and will not receive any commercial support prior to or during this program. For additional information or if accommodations are needed, please contact Jennifer at events@ucebt.com or (801) 419-0139.